JennWangSellersMD

PubMed

• Comparison of Good Clinical Practice Inspection Processes for Marketing Applications Between the United States Food and Drug Administration and the European Medicines ...
  Kassa Ayalew, Yang-Min Ning, Michelle J Foringer, Susan Leibenhaut, Jenn W Sellers, Bei Yu, Phillip D Kronstein, Agata Higgerson, Camelia Mihaescu, Miguel Rodriguez, L...> ;Therapeutic Innovation & Regulatory Science. 2023 Jan 1
• Publisher Correction: Descriptive Analysis of Good Clinical Practice Inspection Findings from U.S. Food and Drug Administration and European Medicines Agency.
  Jenn W Sellers, Camelia M Mihaescu, Kassa Ayalew, Phillip D Kronstein, Bei Yu, Yang-Min Ning, Miguel Rodriguez, LaKisha Williams, Ni A Khin> ;Therapeutic Innovation & Regulatory Science. 2022 Sep 1
• 1 citations
  Descriptive Analysis of Good Clinical Practice Inspection Findings from U.S. Food and Drug Administration and European Medicines Agency.
  Jenn W Sellers, Camelia M Mihaescu, Kassa Ayalew, Phillip D Kronstein, Bei Yu, Yang-Min Ning, Miguel Rodriguez, LaKisha Williams, Ni A Khin> ;Therapeutic Innovation & Regulatory Science. 2022 Sep 1
• Correction to: Descriptive Analysis of Good Clinical Practice Inspection Findings from U.S. Food and Drug Administration and European Medicines Agency.
  Jenn W Sellers, Camelia M Mihaescu, Kassa Ayalew, Phillip D Kronstein, Bei Yu, Yang-Min Ning, Miguel Rodriguez, LaKisha Williams, Ni A Khin> ;Therapeutic Innovation & Regulatory Science. 2022 Sep 1
• 25 citations
  The US Food and Drug Administration's Perspective on the New Antidepressant Vortioxetine
  Jing Zhang, Mitchell V. Mathis, Jenn W. Sellers, George Kordzakhia, Andre J. Jackson, Antonia Dow, Peiling Yang, Linda Fossom, Hao Zhu, Hiren D. Patel, Ellis F. Unger,...> ;The Journal of Clinical Psychiatry. 2015 Jan 1
• Join now to see all